JS05.7.A SURGICAL RE-RESECTION FOR RECURRENT GLIOBLASTOMA: PROGNOSTIC EVALUATION USING THE NOVEL RANO CLASSIFICATION FOR EXTENT OF RESECTION FROM THE RANO RESECT GROUP
Abstract BACKGROUND The value of re-resection in recurrent glioblastoma remains controversial as a randomized trial that specifies intentional incomplete resection cannot be justified ethically. Here, we aimed to (I) explore the prognostic role of extent of re-resection using the previously proposed...
Saved in:
Published in | Neuro-oncology (Charlottesville, Va.) Vol. 25; no. Supplement_2; p. ii10 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
08.09.2023
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
BACKGROUND
The value of re-resection in recurrent glioblastoma remains controversial as a randomized trial that specifies intentional incomplete resection cannot be justified ethically. Here, we aimed to (I) explore the prognostic role of extent of re-resection using the previously proposed RANO classification (based upon residual contrast-enhancing (CE) and non-CE tumor), and to (II) define factors consolidating the surgical effects on outcome.
MATERIAL AND METHODS
The RANO resect group retrospectively compiled a global, eight-center cohort of patients with first recurrence from previously resected glioblastomas. The combined associations of re-resection and other clinical factors with outcome were analyzed. Kaplan-Meier survival analysis and log-rank test were applied to calculate survival, and Cox’s proportional hazard regression models to adjust for multiple variables (significance level: p ≤ 0.05). Propensity score-matched analyses were constructed to mimic randomized clinical trials comparing the different RANO classes.
RESULTS
We studied 681 with first recurrence of IDH-wildtype glioblastomas, including 310 patients who underwent re-resection. Re-resection was associated with prolonged survival even when stratifying for clinical and molecular confounders on multivariate analysis (HR for re-resection: 0.65, CI: 0.5-0.8; p = 0.001); and ≤1 cm3 residual CE tumor was associated with longer survival than non-surgical management. Accordingly, ‘maximal CE resection’ (class 2) had superior survival compared to ‘submaximal CE resection’ (class 3) (median OS after recurrence: 12 vs. 9 months; p = 0.003). Administration of (radio-)chemotherapy further augmented the survival associations of smaller residual CE tumor. The prognostic role of residual CE tumor was confirmed in propensity score analyses. Conversely, ‘supramaximal CE resection’ targeting also non-CE tumor (class 1) was not associated with prolonged survival but frequently accompanied by post-operative deficits, hampering further adjuvant treatment.
CONCLUSION
The RANO resect classification serves to stratify patients with re-resection of glioblastoma. Complete CE resection according to RANO resect class 1 and 2 is prognostic of outcome. The beneficial effects of re-resection might be consolidated by (radio-)chemotherapy, and avoidance of post-operative deficits hampering such treatment is of critical importance. |
---|---|
AbstractList | Abstract
BACKGROUND
The value of re-resection in recurrent glioblastoma remains controversial as a randomized trial that specifies intentional incomplete resection cannot be justified ethically. Here, we aimed to (I) explore the prognostic role of extent of re-resection using the previously proposed RANO classification (based upon residual contrast-enhancing (CE) and non-CE tumor), and to (II) define factors consolidating the surgical effects on outcome.
MATERIAL AND METHODS
The RANO resect group retrospectively compiled a global, eight-center cohort of patients with first recurrence from previously resected glioblastomas. The combined associations of re-resection and other clinical factors with outcome were analyzed. Kaplan-Meier survival analysis and log-rank test were applied to calculate survival, and Cox’s proportional hazard regression models to adjust for multiple variables (significance level: p ≤ 0.05). Propensity score-matched analyses were constructed to mimic randomized clinical trials comparing the different RANO classes.
RESULTS
We studied 681 with first recurrence of IDH-wildtype glioblastomas, including 310 patients who underwent re-resection. Re-resection was associated with prolonged survival even when stratifying for clinical and molecular confounders on multivariate analysis (HR for re-resection: 0.65, CI: 0.5-0.8; p = 0.001); and ≤1 cm3 residual CE tumor was associated with longer survival than non-surgical management. Accordingly, ‘maximal CE resection’ (class 2) had superior survival compared to ‘submaximal CE resection’ (class 3) (median OS after recurrence: 12 vs. 9 months; p = 0.003). Administration of (radio-)chemotherapy further augmented the survival associations of smaller residual CE tumor. The prognostic role of residual CE tumor was confirmed in propensity score analyses. Conversely, ‘supramaximal CE resection’ targeting also non-CE tumor (class 1) was not associated with prolonged survival but frequently accompanied by post-operative deficits, hampering further adjuvant treatment.
CONCLUSION
The RANO resect classification serves to stratify patients with re-resection of glioblastoma. Complete CE resection according to RANO resect class 1 and 2 is prognostic of outcome. The beneficial effects of re-resection might be consolidated by (radio-)chemotherapy, and avoidance of post-operative deficits hampering such treatment is of critical importance. |
Author | van den Bent, M Haddad, A F Grau, S J Sciortino, T Rudà, R Weller, M Karschnia, P Young, J S Molinaro, A M Tandon, N Juenger, S T Morshed, R A Schnell, O Nunez, L Tonn, J Bruno, F Häni, L Esquenazi, Y Beck, J Dono, A Chang, S M Vogelbaum, M A Teske, N Berger, M S Mau, C Y Hervey-Jumper, S Bello, L |
Author_xml | – sequence: 1 givenname: P surname: Karschnia fullname: Karschnia, P – sequence: 2 givenname: A surname: Dono fullname: Dono, A – sequence: 3 givenname: J S surname: Young fullname: Young, J S – sequence: 4 givenname: S T surname: Juenger fullname: Juenger, S T – sequence: 5 givenname: N surname: Teske fullname: Teske, N – sequence: 6 givenname: L surname: Häni fullname: Häni, L – sequence: 7 givenname: T surname: Sciortino fullname: Sciortino, T – sequence: 8 givenname: C Y surname: Mau fullname: Mau, C Y – sequence: 9 givenname: F surname: Bruno fullname: Bruno, F – sequence: 10 givenname: L surname: Nunez fullname: Nunez, L – sequence: 11 givenname: R A surname: Morshed fullname: Morshed, R A – sequence: 12 givenname: A F surname: Haddad fullname: Haddad, A F – sequence: 13 givenname: M surname: Weller fullname: Weller, M – sequence: 14 givenname: M surname: van den Bent fullname: van den Bent, M – sequence: 15 givenname: J surname: Beck fullname: Beck, J – sequence: 16 givenname: S surname: Hervey-Jumper fullname: Hervey-Jumper, S – sequence: 17 givenname: A M surname: Molinaro fullname: Molinaro, A M – sequence: 18 givenname: N surname: Tandon fullname: Tandon, N – sequence: 19 givenname: R surname: Rudà fullname: Rudà, R – sequence: 20 givenname: M A surname: Vogelbaum fullname: Vogelbaum, M A – sequence: 21 givenname: L surname: Bello fullname: Bello, L – sequence: 22 givenname: O surname: Schnell fullname: Schnell, O – sequence: 23 givenname: S J surname: Grau fullname: Grau, S J – sequence: 24 givenname: S M surname: Chang fullname: Chang, S M – sequence: 25 givenname: M S surname: Berger fullname: Berger, M S – sequence: 26 givenname: Y surname: Esquenazi fullname: Esquenazi, Y – sequence: 27 givenname: J surname: Tonn fullname: Tonn, J |
BookMark | eNqdkMFKw0AQQBepYKv-gKf5gaS7CUmqt3XZpCvpTtndFG9LqSkomkiCB7_I32yaFvHsaYaB9wbejEyatqkJuWM0ZPQ-njf1V9vs5k27fWFxFtIovSBTlkRxkCzSdDLuUbBIWHZFZn3_RmnEkpRNyc-TpUmYhRxsZQoleAlGBkZaKZxCDTma4SAqY6R2UJQKH0tuHa74A6wNFhqtUwLkhpcVH4nKKl2AW0rQuJGDjmsEMUBW5YP_1yqf3VGJOfz5ZnA1oiN0ukNhsFrfkMv99r2vb8_zmkS5dGIZ7Lq277t67z-7149t9-0Z9cck_pTEn5P4IUn8L-gAXBNkQw |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1093/neuonc/noad137.026 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1523-5866 |
EndPage | ii10 |
ExternalDocumentID | 10_1093_neuonc_noad137_026 |
GroupedDBID | --- .2P .I3 .XZ .ZR 0R~ 123 18M 2WC 36B 4.4 48X 53G 5VS 5WD 70D AABZA AACZT AAJKP AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAVAP AAYXX ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABPTD ABQLI ABQNK ABWST ABXVV ABZBJ ACGFO ACGFS ACUFI ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHXPO AIAGR AIJHB AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC AOIJS APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CITATION CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS EE~ EMB EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HW0 HYE HZ~ IOX J21 KOP KQ8 KSI KSN MHKGH N9A NGC NOMLY NOYVH O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PEELM Q1. Q5Y RD5 RHF ROX RPM RUSNO RW1 RXO SV3 TEORI TJX TR2 W8F WOQ X7H YAYTL YKOAZ YXANX ~91 |
ID | FETCH-crossref_primary_10_1093_neuonc_noad137_0263 |
ISSN | 1522-8517 |
IngestDate | Thu Sep 12 17:42:00 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_1093_neuonc_noad137_0263 |
ParticipantIDs | crossref_primary_10_1093_neuonc_noad137_026 |
PublicationCentury | 2000 |
PublicationDate | 2023-09-08 |
PublicationDateYYYYMMDD | 2023-09-08 |
PublicationDate_xml | – month: 09 year: 2023 text: 2023-09-08 day: 08 |
PublicationDecade | 2020 |
PublicationTitle | Neuro-oncology (Charlottesville, Va.) |
PublicationYear | 2023 |
SSID | ssj0021561 |
Score | 4.8722596 |
Snippet | Abstract
BACKGROUND
The value of re-resection in recurrent glioblastoma remains controversial as a randomized trial that specifies intentional incomplete... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | ii10 |
Title | JS05.7.A SURGICAL RE-RESECTION FOR RECURRENT GLIOBLASTOMA: PROGNOSTIC EVALUATION USING THE NOVEL RANO CLASSIFICATION FOR EXTENT OF RESECTION FROM THE RANO RESECT GROUP |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuqLxEaUF74GbZLX7EcW8mOGlD4kW2U-Vm2clWKgcbVXEP_UP8Pv4BsztrewNFIlwsZ5UdP-bTemb2mxlCPnCn8Eq_5CYshNemWwaBOeKcmz6YztzeuMNyI-Idi3h4sXRnK281GPzUWEvNtrTW9w_mlfyPVmEM9CqyZPfQbCcUBuAc9AtH0DAc_0nHs_TMs3wrNNJlgi0NksgUW0CSGWKAgwcD42WSRHFmTOeX7NM8TDOGQfWvCZvGLM1ADdFVOF9i_x3RhmMqeUAxu4pAYBgzYwzT0suJSjqWcqNVJoSyiaFdL2ELOVVOwnGN1_-tLRTV3NZmXa2x-pPYRRZb_vUWjN47kZkoqbeFpcUovoD3LUrNFjsJaZ-xbXgfje1Wrlkf0J01graLzcUUIVzFOGxHkrh2lmVwmcE2xE8zb8cc0xthz5Z2LcckaoVZ2RdVBllzW1ujb24UkZbv_PzjW4J1tirewBsRJ3Wx-ej41pn9QOnu3z6pHdERt_idHKXkSkYOMh6Rx7YfeIKFOl11rCQwwFSJX_XAKs8LZJyijFPtPjRbSjOKskPyTHkzNERoPicDXr0gTxaKr_GS_GgRSluEUh2hFJBEO4RSHaHntMcn7fFJJT4pgIxKfFIBNbqLTykV8UnZhGpXA3zKqXISjlOJz1fEnkTZ-MJsHzT_jlVY8r-_Wuc1Oajqir8h9JqPimIUgBU_DFxRXDFw_Q34RJ5drsFRGh4RYw_Bb_f69zF52mP5hBxsbxv-DizYbfle6vwXJxyKiA |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=JS05.7.A+SURGICAL+RE-RESECTION+FOR+RECURRENT+GLIOBLASTOMA%3A+PROGNOSTIC+EVALUATION+USING+THE+NOVEL+RANO+CLASSIFICATION+FOR+EXTENT+OF+RESECTION+FROM+THE+RANO+RESECT+GROUP&rft.jtitle=Neuro-oncology+%28Charlottesville%2C+Va.%29&rft.au=Karschnia%2C+P&rft.au=Dono%2C+A&rft.au=Young%2C+J+S&rft.au=Juenger%2C+S+T&rft.date=2023-09-08&rft.issn=1522-8517&rft.eissn=1523-5866&rft.volume=25&rft.issue=Supplement_2&rft.spage=ii10&rft.epage=ii10&rft_id=info:doi/10.1093%2Fneuonc%2Fnoad137.026&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_neuonc_noad137_026 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1522-8517&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1522-8517&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1522-8517&client=summon |